Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs

Background & Objective: Alzheimer’s disease (AD) is a kind of neuropsychiatric disorder that gradually degrades the mental abilities. High level activity of protein tyrosine phosphatase (PTP) results in memory function loss and Alzheimer disease. Thus, the inhibition of PTP activity can be consi...

Full description

Bibliographic Details
Main Author: fereshteh shiri
Format: Article
Language:English
Published: Fasa University of Medical Sciences 2020-06-01
Series:Journal of Advanced Biomedical Sciences
Subjects:
Online Access:http://jabs.fums.ac.ir/article-1-1617-en.pdf
_version_ 1797679575497441280
author fereshteh shiri
author_facet fereshteh shiri
author_sort fereshteh shiri
collection DOAJ
description Background & Objective: Alzheimer’s disease (AD) is a kind of neuropsychiatric disorder that gradually degrades the mental abilities. High level activity of protein tyrosine phosphatase (PTP) results in memory function loss and Alzheimer disease. Thus, the inhibition of PTP activity can be considered as a potential target for the discovery of anti-Alzheimer drug. In this study, using computational techniques anti-alzheimer drug candidates will be designed. Materials & Methods: The three-dimensional quantitative structure activity relationship (3D-QSAR) computational studies on PTP inhibitors were performed. Accordingly, comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA) methods were used to determine the required factors for the activity of these compounds. Distill module was applied for the alignment of molecules. A number of new active inhibitors have been proposed using the components of the CoMFA model. Molecular attachment studies were performed to investigate the inhibitory mechanism, identify bioactive conformer, and determine key interactions. Finally, ADMET studies (absorption, distribution, metabolism, digestion and toxicity) were performed on these inhibitors in a computer environment and compared with standard ranges. Results: The statistical parameters from the models (CoMFA: q2 =0.653,r2ncv=0.961, r2pred =0.770, and CoMSIA: q2=0.564, r2ncv = 0.933, r2pred= 0.746) indicate that the data are well fitted and have high predictive ability. Based on the information obtained from the constructed models, a novel set of tyrosine phosphatase inhibitors with new molecular frameworks have been introduced as new anti-Alzheimer's drug candidates. Conclusion: Computational techniques play a valuable role in drug design. Optimal r2pred and q2 statistical parameters led to the logical design of a number of new inhibitors of tyrosine phosphatase protein, which were introduced as new antimicrobial drug candidates.
first_indexed 2024-03-11T23:16:46Z
format Article
id doaj.art-a849947102754b669e4248f8058744fb
institution Directory Open Access Journal
issn 2228-5105
2783-1523
language English
last_indexed 2024-03-11T23:16:46Z
publishDate 2020-06-01
publisher Fasa University of Medical Sciences
record_format Article
series Journal of Advanced Biomedical Sciences
spelling doaj.art-a849947102754b669e4248f8058744fb2023-09-20T21:27:15ZengFasa University of Medical SciencesJournal of Advanced Biomedical Sciences2228-51052783-15232020-06-0110223712386Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugsfereshteh shiri012 Department of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran Department of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran Department of Chemistry, Faculty of Science, University of Zabol, Zabol, Iran Background & Objective: Alzheimer’s disease (AD) is a kind of neuropsychiatric disorder that gradually degrades the mental abilities. High level activity of protein tyrosine phosphatase (PTP) results in memory function loss and Alzheimer disease. Thus, the inhibition of PTP activity can be considered as a potential target for the discovery of anti-Alzheimer drug. In this study, using computational techniques anti-alzheimer drug candidates will be designed. Materials & Methods: The three-dimensional quantitative structure activity relationship (3D-QSAR) computational studies on PTP inhibitors were performed. Accordingly, comparative molecular field analysis (CoMFA), and comparative molecular similarity indices analysis (CoMSIA) methods were used to determine the required factors for the activity of these compounds. Distill module was applied for the alignment of molecules. A number of new active inhibitors have been proposed using the components of the CoMFA model. Molecular attachment studies were performed to investigate the inhibitory mechanism, identify bioactive conformer, and determine key interactions. Finally, ADMET studies (absorption, distribution, metabolism, digestion and toxicity) were performed on these inhibitors in a computer environment and compared with standard ranges. Results: The statistical parameters from the models (CoMFA: q2 =0.653,r2ncv=0.961, r2pred =0.770, and CoMSIA: q2=0.564, r2ncv = 0.933, r2pred= 0.746) indicate that the data are well fitted and have high predictive ability. Based on the information obtained from the constructed models, a novel set of tyrosine phosphatase inhibitors with new molecular frameworks have been introduced as new anti-Alzheimer's drug candidates. Conclusion: Computational techniques play a valuable role in drug design. Optimal r2pred and q2 statistical parameters led to the logical design of a number of new inhibitors of tyrosine phosphatase protein, which were introduced as new antimicrobial drug candidates.http://jabs.fums.ac.ir/article-1-1617-en.pdfthree-dimensional quantitative structure activity relationshiptyrosine phosphatasemolecular dockingpharmacokinetics
spellingShingle fereshteh shiri
Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
Journal of Advanced Biomedical Sciences
three-dimensional quantitative structure activity relationship
tyrosine phosphatase
molecular docking
pharmacokinetics
title Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
title_full Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
title_fullStr Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
title_full_unstemmed Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
title_short Three-Dimensional Quantitative Structure-Activity Relationship Analysis and Molecular Docking of some Nonpeptidic Inhibitors of Protein Tyrosine Phosphatase as Anti-Alzheimer Drugs
title_sort three dimensional quantitative structure activity relationship analysis and molecular docking of some nonpeptidic inhibitors of protein tyrosine phosphatase as anti alzheimer drugs
topic three-dimensional quantitative structure activity relationship
tyrosine phosphatase
molecular docking
pharmacokinetics
url http://jabs.fums.ac.ir/article-1-1617-en.pdf
work_keys_str_mv AT fereshtehshiri threedimensionalquantitativestructureactivityrelationshipanalysisandmoleculardockingofsomenonpeptidicinhibitorsofproteintyrosinephosphataseasantialzheimerdrugs